Q32 Bio, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7469641051
USD
6.91
0.92 (15.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
53.74
0.00
-6.65
3.21
33.97
2.70
1.67
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
53.74
0.00
-6.65
3.21
33.97
2.70
1.67
Raw Material Cost
0.39
0.49
0.50
2.60
9.54
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.10
0.30
1.50
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
17.29
17.47
9.38
35.54
27.29
23.67
15.89
Other Expenses
1.81
4.78
3.02
9.84
9.31
10.04
8.94
Total Expenditure (Excl Depreciation)
36.84
66.10
41.60
136.49
129.92
124.06
105.29
Operating Profit (PBDIT) excl Other Income
16.9
-66.10000000000001
-48.3
-133.3
-95.9
-121.4
-103.6
Other Income
13.62
2.92
2.52
134.48
0.18
1.57
6.03
Operating Profit (PBDIT)
30.91
-62.69
-45.23
3.80
-86.22
-119.79
-97.60
Interest
1.10
0.30
1.50
0.00
0.00
0.00
0.00
Exceptional Items
0.40
17.39
-6.19
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
53.35
-0.49
-7.15
0.61
24.43
0.00
0.00
Depreciation
0.39
0.49
0.50
2.60
9.54
8.90
6.32
Profit Before Tax
29.82
-46.09
-53.42
1.20
-95.76
-128.69
-103.92
Tax
0.00
0.02
0.32
0.71
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
29.82
-47.73
-53.74
-5.00
-95.76
-128.69
-103.92
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
29.82
-47.73
-53.74
-5.00
-95.76
-128.69
-103.92
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
29.82
-47.73
-53.74
-5.00
-95.76
-128.69
-103.92
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
42.01
5.67
-182.92
177.98
169.65
196.00
258.51
Earnings per share (EPS)
2.42
-6.58
-153.97
-1.57
-31.18
-50.46
-44.41
Diluted Earnings per share
2.42
-6.58
-153.97
-1.57
-31.18
-50.46
-44.41
Operating Profit Margin (Excl OI)
31.45%
0.0%
0.0%
-4154.64%
-282.44%
-4820.98%
-6599.22%
Gross Profit Margin
56.22%
0.0%
795.76%
118.36%
-253.8%
-4433.38%
-5858.22%
PAT Margin
55.49%
0.0%
0.0%
-156.02%
-281.9%
-4762.92%
-6237.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 0.00% vs 100.00% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 162.47% vs 11.17% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 126.37% vs -37.24% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 266.67% vs -80.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Q32 Bio, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
53.74
0
53.74
Other Operating Income
0.00
0.00
0.00
Total Operating income
53.74
0
53.74
Raw Material Cost
0.39
0
0.39
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.10
0
1.10
Selling and Distribution Expenses
17.29
0
17.29
Other Expenses
1.81
0.00
1.81
Total Expenditure (Excl Depreciation)
36.84
0
36.84
Operating Profit (PBDIT) excl Other Income
16.90
0.00
16.90
Other Income
13.62
0
13.62
Operating Profit (PBDIT)
30.91
0
30.91
Interest
1.10
0
1.10
Exceptional Items
0.40
0
0.40
Gross Profit (PBDT)
53.35
0
53.35
Depreciation
0.39
0
0.39
Profit Before Tax
29.82
0
29.82
Tax
0.00
0
0.00
Provisions and contingencies
0
0
0.00
Profit After Tax
29.82
0
29.82
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
29.82
0
29.82
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
29.82
0
29.82
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
42.01
0
42.01
Earnings per share (EPS)
2.42
0
2.42
Diluted Earnings per share
2.42
0
2.42
Operating Profit Margin (Excl OI)
31.45%
0%
0.00
31.45%
Gross Profit Margin
56.22%
0%
0.00
56.22%
PAT Margin
55.49%
0%
0.00
55.49%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 5.37 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 0.00% vs 100.00% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 2.98 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 162.47% vs 11.17% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.73 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 126.37% vs -37.24% in Dec 2024

Annual - Interest
Interest 0.11 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 266.67% vs -80.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.45%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024